Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NSE - Delayed Quote INR

Concord Biotech Limited (CONCORDBIO.NS)

Compare
1,496.10
-93.20
(-5.86%)
At close: February 28 at 3:30:00 PM GMT+5:30
Currency in INR All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
10,702,906
9,980,573
8,306,322
7,084,400
6,040,530
Cost of Revenue
2,782,714
2,416,100
1,970,667
1,779,230
1,203,260
Gross Profit
7,920,192
7,564,473
6,335,655
5,305,170
4,837,270
Operating Expense
3,869,803
3,701,646
3,288,198
2,943,900
1,804,750
Operating Income
4,050,389
3,862,827
3,047,457
2,361,270
3,032,520
Net Non Operating Interest Income Expense
15,124
-1,429
-7,437
-13,480
7,400
Pretax Income
4,397,297
4,125,650
3,220,134
2,375,180
3,127,200
Tax Provision
1,134,583
1,044,618
819,277
625,890
778,330
Net Income Common Stockholders
3,262,714
3,081,032
2,400,857
1,749,290
2,348,870
Diluted NI Available to Com Stockholders
3,262,714
3,081,032
2,400,857
1,749,290
2,348,870
Basic EPS
31.19
29.45
22.95
16.72
22.45
Diluted EPS
31.19
29.45
22.95
16.72
22.45
Basic Average Shares
104,604.80
104,616.20
104,616.20
104,616.20
104,616.20
Diluted Average Shares
104,604.80
104,616.20
104,616.20
104,616.20
104,616.20
Rent Expense Supplemental
--
85,581
58,980
20
40
Total Expenses
6,652,517
6,117,746
5,258,865
4,723,130
3,008,010
Net Income from Continuing & Discontinued Operation
3,262,714
3,081,032
2,400,857
1,749,290
2,348,870
Normalized Income
3,157,219.04
2,975,150.55
2,369,286.10
1,756,323.58
2,300,040.99
Interest Income
--
30,411
44,408
47,870
17,870
Interest Expense
8,966
25,519
45,103
54,840
6,660
Net Interest Income
15,124
-1,429
-7,437
-13,480
7,400
EBIT
4,406,263
4,151,169
3,265,237
2,430,020
3,133,860
EBITDA
4,941,012
4,687,084
3,805,561
2,930,520
3,409,090
Reconciled Cost of Revenue
2,782,714
2,416,100
1,970,667
1,779,230
1,203,260
Reconciled Depreciation
534,749
535,915
540,324
500,500
275,230
Net Income from Continuing Operation Net Minority Interest
3,262,714
3,081,032
2,400,857
1,749,290
2,348,870
Total Unusual Items Excluding Goodwill
142,180
142,180
42,434
-9,550
65,010
Total Unusual Items
142,180
142,180
42,434
-9,550
65,010
Normalized EBITDA
4,798,832
4,544,904
3,763,127
2,940,070
3,344,080
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
36,685.04
36,298.55
10,863.10
-2,516.43
16,180.99
3/31/2021 - 8/18/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade